Scarica l'app Stockscreener
4.35
7.94%
0.32
Fulcrum Therapeutics Inc Azioni (FULC) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
100.00%
-
|
0.871 | 0.759 | 0.88 | 0.295 |
Operating Expenses
|
3.36%
29.83
|
28.86 | 28.20 | 28.17 | 28.23 |
| Operating Income/Loss |
6.58%
-29.83
|
-27.99 | -27.44 | -27.29 | -27.94 |
| Income/Loss From Continuing Operations Before Tax |
8.54%
-26.87
|
-24.76 | 0.759 | -23.78 | -24.78 |
| Income/Loss From Continuing Operations After Tax |
8.54%
-26.87
|
-24.76 | -24.02 | -23.78 | -24.78 |
|
Net Income/Loss
|
8.54%
-26.87
|
-24.76 | -24.02 | -23.78 | -24.78 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
32,696%
0.062
|
0.000189 | 0.0618 | 0.0618 | 0.0597 |
| Diluted Average Shares |
32,696%
0.062
|
0.000189 | 0.0618 | 0.0618 | 0.0597 |
| Basic Earnings Per Share |
7.50%
-0.43
|
-0.40 | -0.39 | -0.38 | -0.41 |
| Diluted Earnings Per Share |
7.50%
-0.43
|
-0.40 | -0.39 | -0.38 | -0.41 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):